Professor Irving W Wainer is Chief Scientific Office for Mitchell Woods Pharmaceuticals. He received his PhD degree in chemistry from Cornell University and did postdoctoral doctoral studies in molecular biology (University of Oregon) and clinical pharmacology (Thomas Jefferson Medical School). He worked for the FDA as a Research Chemist, at St. Jude’s Children’s Research Hospital (Associate Member), McGill University (Professor, Department of Oncology), Georgetown University (Professor, Department of Pharmacology) and as Senior Investigator, National Institute on Aging/NIH. Professor Wainer has published 390 scientific papers, 10 books, holds 11 patents, was Founding Editor of the journal Chirality and Senior Editor of the Journal of Chromatography B. His awards include: the “A.J.P. Martin Medal” presented by The Chromatographic Society; Elected Fellow of the American Academy of Pharmaceutical Sciences; Doctor Honoris Causa degrees awarded by the Medical University of Gdansk and University of Liege, the 2013 Dal Nogare Award and the 2013 Eastern Analytical Symposium Award for Outstanding Contributions to the Fields of Analytical Chemistry. Prof. Wainer’s laboratory is also engaged in studies that employ targeted and non-targeted pharmacometabolomics, molecular and cellular biology, cellular pharmacology and pharmacokinetics-pharmacodynamics, as well as chemometric analysis of the data obtained from these studies. Professor Wainer’s laboratory is currently engaged in the development of new therapeutic agents for the treatment of oncologic and CNS diseases and the translation of these agents from the laboratory to the clinic.